Advertisement

Biotricity, Inc. BTCY

Set alert

Price alert · BTCY

All alert types
0.06 USD 0.00 -5.17%

At close · Oct 30

0.055 Day range 0.058
0.0409 52-week range 0.59
YTD
-81.67%
1 year
-90.00%
Open
0.058
Prev close
0.058
Mkt cap
1.11M
Vol
55.32K
Avg vol
43.04K
EPS
-0.13
P/E
0.00
Div yield
0.00%
More statistics
Low
0.055
High
0.058
Forward P/E
-0.96
Beta
1.36
Short ratio
5.50
Inst. own
4.18%
Dividend
0.00
Ex-div date
50-d avg
0.660471
200-d avg
1.00
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 14, 2024Earnings: -0.07; estimate 0; surprise —%
Signals (91)
NameDateAgo
MACD: Buy SignalOct 14, 20262 weeks ago
RSI: OversoldOct 12, 20262 weeks ago
RSI: OversoldOct 5, 20263 weeks ago
SMA: BearishSep 1, 20262 months ago
MACD: Sell SignalSep 1, 20262 months ago
SMA: BullishAug 28, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BullishAug 26, 20262 months ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 18, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
MACD: Sell SignalAug 3, 20263 months ago
MACD: Buy SignalJul 22, 20263 months ago
MACD: Sell SignalJul 17, 20263 months ago
MACD: Buy SignalJun 5, 20264 months ago
RSI: OversoldMay 20, 20265 months ago
SMA: BearishMay 14, 20265 months ago
MACD: Sell SignalMay 14, 20265 months ago
SMA: BullishMay 13, 20265 months ago
SMA: BearishMay 12, 20265 months ago
SMA: BullishMay 7, 20265 months ago
SMA: BearishMay 6, 20265 months ago
SMA: BullishMay 1, 20266 months ago
MACD: Buy SignalMay 1, 20266 months ago
MACD: Sell SignalApr 21, 20266 months ago
SMA: BearishApr 17, 20266 months ago
SMA: BullishApr 15, 20266 months ago
SMA: BearishApr 10, 20266 months ago
SMA: BullishApr 9, 20266 months ago
SMA: BearishMar 30, 20267 months ago
SMA: BullishMar 27, 20267 months ago
MACD: Buy SignalMar 23, 20267 months ago
MACD: Sell SignalMar 18, 20267 months ago
MACD: Buy SignalMar 13, 20267 months ago
MACD: Sell SignalMar 6, 20268 months ago
MACD: Buy SignalJan 7, 20269 months ago
MACD: Sell SignalDec 8, 202510 months ago
MACD: Buy SignalDec 5, 202511 months ago
MACD: Sell SignalDec 4, 202511 months ago
SMA: BearishDec 2, 202511 months ago
SMA: BullishDec 1, 202511 months ago
MACD: Buy SignalDec 1, 202511 months ago
SMA: BearishNov 26, 202511 months ago
SMA: BullishNov 25, 202511 months ago
SMA: BearishNov 18, 202511 months ago
MACD: Sell SignalOct 29, 20251 year ago
SMA: BearishOct 28, 20251 year ago
SMA: BullishOct 27, 20251 year ago
MACD: Buy SignalOct 27, 20251 year ago
SMA: BearishOct 24, 20251 year ago
SMA: BullishOct 23, 20251 year ago
MACD: Sell SignalOct 21, 20251 year ago
SMA: BearishOct 20, 20251 year ago
MACD: Buy SignalOct 10, 20251 year ago
SMA: BullishOct 9, 20251 year ago
SMA: BearishSep 29, 20251 year ago
MACD: Sell SignalSep 17, 20251 year ago
SMA: BullishAug 11, 20251 year ago
SMA: BearishAug 8, 20251 year ago
MACD: Buy SignalAug 6, 20251 year ago
SMA: BullishAug 5, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
MACD: Buy SignalJul 11, 20251 year ago
SMA: BearishJun 18, 20251 year ago
MACD: Sell SignalJun 9, 20251 year ago
MACD: Buy SignalJun 5, 20251 year ago
MACD: Sell SignalJun 3, 20251 year ago
MACD: Buy SignalMay 29, 20251 year ago
MACD: Sell SignalMay 28, 20251 year ago
MACD: Buy SignalMay 23, 20251 year ago
SMA: BullishMay 16, 20251 year ago
SMA: BearishMay 15, 20251 year ago
MACD: Sell SignalMay 15, 20251 year ago
SMA: BullishMay 1, 20251 year ago
SMA: BearishApr 17, 20251 year ago
SMA: BullishApr 16, 20251 year ago
MACD: Buy SignalApr 11, 20251 year ago
SMA: BearishMar 24, 20251 year ago
SMA: BullishMar 21, 20251 year ago
SMA: BearishMar 18, 20251 year ago
MACD: Sell SignalMar 3, 20251 year ago
RSI: OverboughtFeb 19, 20251 year ago
MACD: Buy SignalFeb 18, 20251 year ago
MACD: Sell SignalFeb 10, 20251 year ago
MACD: Buy SignalJan 29, 20251 year ago
SMA: BullishJan 24, 20251 year ago
SMA: BearishJan 23, 20251 year ago
MACD: Sell SignalJan 21, 20251 year ago
RSI: OverboughtJan 7, 20251 year ago

Key statistics

Market cap
9.37M
Enterprise value
35.30M
Trailing P/E
0.00
Forward P/E
-0.96
PEG ratio
0.00
Price / sales
0.77
Price / book
0.00
EPS (TTM)
-1.74
Beta
1.36
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-117.41%
Revenue (TTM)
12.24M
Revenue growth
6.00%
Free cash flow
-4.35M
Total cash
662.98K
Total debt
23.09M
Return on equity
0.00%
Shares outstanding
22.45M
Short % of float
2.31%
50-day average
0.660471
200-day average
1.00

Analyst view

Consensus: hold

Hold
Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
BTCY Revenue — quarterly 3.18M
2021-Q1 20202021-Q2 20202021-Q3 20202021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 2024
BTCY Net income — quarterly -4.18M
2021-Q1 20202021-Q2 20202021-Q3 20202021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 2024
BTCY EPS — quarterly -0.469
2021-Q1 20202021-Q2 20202021-Q3 20202021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 2024

Earnings

BTCY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-0.07——
Aug 19, 2024Jun 1, 20240.00-0.49——
Jun 26, 2024Mar 1, 2024-0.36-0.47-0.11-30.56%
Feb 20, 2024Dec 1, 2023-0.41-0.34+0.07+17.07%
Nov 14, 2023Sep 1, 2023-0.34-0.44-0.10-29.41%
Aug 14, 2023Jun 1, 2023-0.41-0.07+0.34+82.93%

Upgrades / downgrades

BTCY analyst upgrades and downgrades
DateFirmActionFromTo
Jul 4, 2023HC Wainwright & Co.reitBuyBuy

About Biotricity, Inc.

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity, Inc. is based in Redwood City, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on BTCY — it syncs with the Stock Master app.

Insider holders

BTCY insider holders
InsiderRelationLatest transactionDateShares held
BETTS NORMAN MURRAY PH.D.DirectorStock Award(Grant)Nov 28, 2021375,598
BETTS NORMAN PH.D.DirectorStock Award(Grant)Apr 6, 2020321,250
KENNEDY PATRICIA JDirectorStock Award(Grant)Apr 6, 2020250,000
ROSA DAVID ADirectorStock Award(Grant)Nov 28, 2021152,174

Institution ownership

BTCY institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc2.89%247,211945.58KJun 29, 2023
Geode Capital Management, LLC0.75%64,034244.93KJun 29, 2023
Strengthening Families & Communities, LLC0.56%48,263184.60KJun 29, 2023
AE Wealth Management LLC0.49%41,68489.20KSep 29, 2023
State Street Corporation0.26%22,54986.25KJun 29, 2023
Blackrock Inc.0.16%13,37451.16KJun 29, 2023

Fund ownership

BTCY fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.65%140,956539.16KJun 29, 2023
Vanguard Extended Market Index Fund1.07%91,890351.48KJun 29, 2023
Fidelity Extended Market Index Fund0.41%35,034145.04KMay 30, 2023
Fidelity Total Market Index Fund0.12%9,98541.34KMay 30, 2023
Fidelity Series Total Market Index Fund0.09%8,00133.12KMay 30, 2023
Vanguard Balanced Index Fund0.08%7,13327.28KJun 29, 2023
Advertisement